381 related articles for article (PubMed ID: 32397070)
1. Where do we Stand after Decades of Studying Human Cytomegalovirus?
Gugliesi F; Coscia A; Griffante G; Galitska G; Pasquero S; Albano C; Biolatti M
Microorganisms; 2020 May; 8(5):. PubMed ID: 32397070
[TBL] [Abstract][Full Text] [Related]
2. Overview of Human Cytomegalovirus Pathogenesis.
Fulkerson HL; Nogalski MT; Collins-McMillen D; Yurochko AD
Methods Mol Biol; 2021; 2244():1-18. PubMed ID: 33555579
[TBL] [Abstract][Full Text] [Related]
3. Drug targets in cytomegalovirus infection.
Andrei G; De Clercq E; Snoeck R
Infect Disord Drug Targets; 2009 Apr; 9(2):201-22. PubMed ID: 19275707
[TBL] [Abstract][Full Text] [Related]
4. Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency.
Caviness K; Bughio F; Crawford LB; Streblow DN; Nelson JA; Caposio P; Goodrum F
mBio; 2016 Mar; 7(2):e01986. PubMed ID: 26933055
[TBL] [Abstract][Full Text] [Related]
5. Restriction of Human Cytomegalovirus Infection by Galectin-9.
Machala EA; Avdic S; Stern L; Zajonc DM; Benedict CA; Blyth E; Gottlieb DJ; Abendroth A; McSharry BP; Slobedman B
J Virol; 2019 Feb; 93(3):. PubMed ID: 30487283
[TBL] [Abstract][Full Text] [Related]
6. Human Cytomegalovirus UL135 and UL136 Genes Are Required for Postentry Tropism in Endothelial Cells.
Bughio F; Umashankar M; Wilson J; Goodrum F
J Virol; 2015 Jul; 89(13):6536-50. PubMed ID: 25878111
[TBL] [Abstract][Full Text] [Related]
7. Development of a Primary Human Cell Model for the Study of Human Cytomegalovirus Replication and Spread within Salivary Epithelium.
Morrison KM; Beucler MJ; Campbell EO; White MA; Boody RE; Wilson KC; Miller WE
J Virol; 2019 Feb; 93(3):. PubMed ID: 30404806
[TBL] [Abstract][Full Text] [Related]
8. Human Cytomegalovirus Induces an Atypical Activation of Akt To Stimulate the Survival of Short-Lived Monocytes.
Cojohari O; Peppenelli MA; Chan GC
J Virol; 2016 Jul; 90(14):6443-6452. PubMed ID: 27147739
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infections.
Khoshnevis M; Tyring SK
Dermatol Clin; 2002 Apr; 20(2):291-9, vii. PubMed ID: 12120442
[TBL] [Abstract][Full Text] [Related]
10. The human cytomegalovirus.
Landolfo S; Gariglio M; Gribaudo G; Lembo D
Pharmacol Ther; 2003 Jun; 98(3):269-97. PubMed ID: 12782241
[TBL] [Abstract][Full Text] [Related]
11. Human Cytomegalovirus Stimulates the Synthesis of Select Akt-Dependent Antiapoptotic Proteins during Viral Entry To Promote Survival of Infected Monocytes.
Peppenelli MA; Arend KC; Cojohari O; Moorman NJ; Chan GC
J Virol; 2016 Jan; 90(6):3138-47. PubMed ID: 26739047
[TBL] [Abstract][Full Text] [Related]
12. Summary of the II International Symposium on Cytomegalovirus.
de Jong MD; Galasso GJ; Gazzard B; Griffiths PD; Jabs DA; Kern ER; Spector SA
Antiviral Res; 1998 Oct; 39(3):141-62. PubMed ID: 9833956
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the Human Cytomegalovirus US20 Gene Hampers Productive Viral Replication in Endothelial Cells.
Cavaletto N; Luganini A; Gribaudo G
J Virol; 2015 Nov; 89(21):11092-106. PubMed ID: 26311874
[TBL] [Abstract][Full Text] [Related]
14. Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.
Yue Y; Barry PA
Adv Virus Res; 2008; 72():207-26. PubMed ID: 19081492
[TBL] [Abstract][Full Text] [Related]
15. Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of
Jackson JW; Hancock TJ; Dogra P; Patel R; Arav-Boger R; Williams AD; Kennel SJ; Wall JS; Sparer TE
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760613
[TBL] [Abstract][Full Text] [Related]
16. Bioactive Molecules Released From Cells Infected with the Human Cytomegalovirus.
Luganini A; Terlizzi ME; Gribaudo G
Front Microbiol; 2016; 7():715. PubMed ID: 27242736
[TBL] [Abstract][Full Text] [Related]
17. Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors.
Kiener R; Fleischmann M; Wiegand MA; Lemmermann NAW; Schwegler C; Kaufmann C; Renzaho A; Thomas S; Felder E; Niller HH; Asbach B; Wagner R
J Virol; 2018 Aug; 92(15):. PubMed ID: 29769344
[TBL] [Abstract][Full Text] [Related]
18. Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance.
Piret J; Boivin G
Antiviral Res; 2019 Mar; 163():91-105. PubMed ID: 30690043
[TBL] [Abstract][Full Text] [Related]
19. APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.
Weisblum Y; Oiknine-Djian E; Zakay-Rones Z; Vorontsov O; Haimov-Kochman R; Nevo Y; Stockheim D; Yagel S; Panet A; Wolf DG
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956761
[TBL] [Abstract][Full Text] [Related]
20. The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
Oiknine-Djian E; Weisblum Y; Panet A; Wong HN; Haynes RK; Wolf DG
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
